Drug yields high response rates for lung cancer patients with harsh mutation
(University of Texas M. D. Anderson Cancer Center) A targeted therapy resurrected by the Moon Shots Program at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries a highly treatment-resistant mutation.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news